Skip to main content

Table 2 Comparison of biopsy outcomes with two different approaches: (a) SBs vs TBs from lesions scored PI-RADS 35 and (b) SBs vs TBs from lesions scored PI-RADS 4–5

From: Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients

PI-RADS 3–5

SBs

TBs

Difference %

 Pt. no

40

29

 − 27.5%

 Biopsy cores no

480

64

 − 86.7%

 PCa detection rate

15

15

0%

 I/H risk PCa detection rate

9

8

 − 11.1%

 Low-risk PCa detection rate

6

7

16.7%

PI-RADS 4–5

SBs

TBs

Difference %

 Pt. no

40

11

 − 72.5%

 Biopsy cores no

480

26

 − 94.6%

 PCa detection rate

15

11

 − 26.7%

 I/H risk detection rate

9

8

 − 11.1%

 Low-risk detection rate

6

3

 − 50.0%